Research is advancing treatment options for patients with severe uveitis
Uveitis specialist Lana Rifkin, MD, presented results from the TRS4 Vision trial at the 26th annual American Uveitis Society Winter Symposium in Park City, Utah. The trial evaluated the safety and efficacy of TRS01 eye drops in the treatment of active non-infectious anterior uveitis, a potentially blinding autoimmune eye inflammation, considered the third leading cause of blindness…
Read More
